Document:

EXHIBIT 10.4

SIXTH AMENDMENT TO CREDIT AGREEMENT

This SIXTH AMENDMENT TO CREDIT AGREEMENT, dated as of April 4, 2017 (this "Amendment"), modifies that certain Credit Agreement, dated as of December 11, 2013 (as amended, restated, extended, supplemented or otherwise modified in writing from time to time, the "Credit Agreement"), among EMERGENT BIOSOLUTIONS INC., a Delaware corporation (the "Borrower"), each Domestic Subsidiary of the Borrower from time to time party thereto as a Guarantor, each lender from time to time party thereto (collectively, the "Lenders" and individually, a "Lender"), and BANK OF AMERICA, N.A., as administrative agent (in such capacity, the "Administrative Agent"), Swing Line Lender and L/C Issuer.  Capitalized terms used herein and not defined shall have the meaning assigned to such terms in the Credit Agreement.

RECITALS

WHEREAS, the Borrower has requested that the Administrative Agent and the Lenders agree to amend certain of the terms and provisions of the Credit Agreement, as specifically set forth in this Amendment; and

WHEREAS, the Administrative Agent and each of the undersigned Lenders are prepared to amend the Credit Agreement, in each case, on the terms, subject to the conditions and in reliance on the representations set forth herein.

NOW THEREFORE, in consideration of the premises and the mutual agreements contained here, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows:

Section 1. Amendment to Credit Agreement.

(a) Section 1.01 (Defined Terms) is hereby amended by restating the following definitions contained in such Section in its entirety as follows:

"L/C Issuer" means each of (a) Bank of America, N.A., or any successor issuer thereof, (b) JPMorgan Chase Bank, N.A. or any successor issuer thereof ("JPM"), (c) PNC Bank, National Association, or any successor issuer thereof ("PNC"), (d) such other Lender selected by the Borrower pursuant to Section 2.03(n) from time to time to issue Letters of Credit (provided that no Lender shall be required to become an L/C Issuer pursuant to this subclause (d) without such Lender's consent), or any successor issuer thereof or (e) any Lender selected by the Borrower (with the prior consent of the Administrative Agent) to replace a Lender who is a Defaulting Lender at the time of such Lender's appointment as an L/C Issuer (provided that no Lender shall be required to become an L/C Issuer pursuant to this subclause (e) without such Lender's consent), or any successor issuer thereof, in each case, in their respective capacities as an issuer of Letters of Credit hereunder.  References herein to "L/C Issuer" or "the L/C Issuer" shall mean, as applicable, and as the context may require (as reasonably determined by Administrative Agent), each L/C Issuer, each applicable or relevant L/C Issuer with respect to any Letter of Credit and/or all L/C Issuers with respect to all Letters of Credit.

(b) Section 1.01 (Defined Terms) is hereby amended by inserting the following new definitions in the appropriate alphabetical order:

"L/C Issuer Sublimits" means, as of the Closing Date, (i) $8,333,333, in the case of Bank of America, (ii) $8,333,333, in the case of JPM, (iii) $8,333,333, in the case of PNC, and (iv) such amount as shall be designated to the Administrative Agent and the Borrower in writing by an L/C Issuer; provided that any L/C Issuer shall be permitted at any time to increase its L/C Issuer Sublimit upon providing five (5) days' prior written notice thereof to the Administrative Agent and the Borrower to an amount not exceeding the Letter of Credit Sublimit.

"Letter of Credit Report" means a certificate in substantially a form approved by the Administrative Agent.

"Notice of Additional L/C Issuer" means a certificate substantially in a form approved by the Administrative Agent.

(a) Section 2.03(a)(i) (The Letter of Credit Commitment) is hereby amended by inserting the following sentence at the end of such Section 2.03(a)(i):

Notwithstanding the foregoing or anything to the contrary contained herein, no L/C Issuer shall be obligated to issue. amend or extend any Letter of Credit if, immediately after giving effect thereto, the outstanding L/C Obligations in respect of all Letters of Credit issued by such L/C Issuer would exceed such Person's L/C Issuer Sublimit.

(b) Section 2.03 (Letters of Credit) is hereby amended by inserting the following new subsections (n) and (o) in the appropriate alphabetical order:

(n) L/C Issuer Reports to the Administrative Agent.  Unless otherwise agreed by the Administrative Agent, each L/C Issuer (other than Bank of America, N.A.) shall, in addition to its notification obligations set forth elsewhere in this Section, provide the Administrative Agent a Letter of Credit Report, as set forth below:

(i) reasonably prior to the time that such L/C Issuer issues, amends, renews, increases or extends a Letter of Credit, the date of such issuance, amendment, renewal, increase or extension and the stated amount of the applicable Letters of Credit after giving effect to such issuance, amendment, renewal or extension (and whether the amounts thereof shall have changed);

(ii) on each Business Day on which such L/C Issuer makes a payment pursuant to a Letter of Credit, the date and amount of such payment;

(iii) on any Business Day on which the Borrower fails to reimburse a payment made pursuant to a Letter of Credit required to be reimbursed to such L/C Issuer on such day, the date of such failure and the amount of such payment;

(iv) on any other Business Day, such other information as the Administrative Agent shall reasonably request as to the Letters of Credit issued by such L/C Issuer; and

(v) for so long as any Letter of Credit issued by an L/C Issuer is outstanding, such L/C Issuer shall deliver to the Administrative Agent (A) on the last Business Day of each calendar month, (B) at all other times a Letter of Credit Report is required to be delivered pursuant to this Agreement, and (C) on each date that (1) an L/C Credit Extension occurs or (2) there is any expiration, cancellation and/or disbursement, in each case, with respect to any such Letter of Credit, a Letter of Credit Report appropriately completed with the information for every outstanding Letter of Credit issued by such L/C Issuer.

(o) Additional L/C Issuers.  Any Lender hereunder may become an L/C Issuer upon receipt by the Administrative Agent of a fully executed Notice of Additional L/C Issuer which shall be signed by the Borrower, the Administrative Agent and each L/C Issuer.

Section 2. New L/C Issuer.  By its signature below, each of JPM and PNC hereby acknowledges and agrees that, from and after the effectiveness of this Amendment,  each of JPM and PNC shall be an L/C Issuer under the Credit Agreement, with all rights and obligations of an L/C Issuer thereunder.

Section 3. Conditions Precedent.  This Amendment shall become effective as of the date first written above (the "Effective Date") upon the satisfaction of the following conditions precedent:

(a) Documentation.  Administrative Agent shall have received all of the following, in form and substance satisfactory to Administrative Agent:

	
(i)

	
a fully-executed and effective Amendment executed by the Borrower, the Guarantors, the Administrative Agent and the Required Lenders; and

	
(ii)

	
such additional documents, instruments and information as Administrative Agent may reasonably request in connection with the transactions contemplated hereby.

(b) No Default.  On the Effective Date and after giving effect to this Amendment, no event shall have occurred and be continuing that would constitute a Default or an Event of Default.

Section 4. Representations and Warranties; Reaffirmation of Grant.  Each Loan Party hereby represents and warrants to the Administrative Agent and the Lenders that, as of the date hereof and after giving effect to this Amendment: (a) all representations and warranties of the Borrower and each other Loan Party set forth in the Credit Agreement and in any other Loan Document are true and correct in all material respects (except that such materiality qualifier shall not be applicable to any representations and warranties that already are qualified or modified by materiality in the text thereof) on and as of the date hereof, except to the extent such representations and warranties specifically relate to an earlier date, in which case such representations and warranties shall have been true and correct in all material respects as of such earlier date (except that such materiality qualifier shall not be applicable to any representations and warranties that already are qualified or modified by materiality in the text thereof), (b) no Default or Event of Default has occurred and is continuing, (c) the Credit Agreement and all other Loan Documents are and remain legally valid, binding obligations of the Loan Parties party thereto, enforceable against each such Loan Party in accordance with their respective terms, subject to bankruptcy, insolvency, reorganization, moratorium and other laws applicable to creditors' rights generally and subject to general principles of equity, and (d) the provisions of the Collateral Documents to which such Loan Party is a party are effective to create in favor of the Administrative Agent for the benefit of the Secured Parties a legal, valid and enforceable first priority Lien (subject only to Liens permitted by Section 7.01 of the Credit Agreement) on all right, title and interest of the respective Loan Parties in the Collateral described therein and do and shall continue to secure the payment of all Obligations as set forth in such respective Collateral Documents.  Each Loan Party hereby reaffirms its grant of a security interest in the Collateral to the Administrative Agent for the benefit of the Secured Parties, as security for the payment and performance in full of the Obligations.

Section 5. Survival of Representations and Warranties.  All representations and warranties made in this Amendment or any other Loan Document shall survive the execution and delivery of this Amendment, and no investigation by the Administrative Agent or the Lenders shall affect the representations and warranties or the right of the Administrative Agent and the Lenders to rely upon them.

Section 6. Amendment as Loan Document.  This Amendment constitutes a "Loan Document" under the Credit Agreement.  Accordingly, it shall be an immediate Event of Default under the Credit Agreement if any representation, warranty, certification or statement of fact made by any Loan Party under or in connection with this Amendment shall have been incorrect or misleading in any material respect when made or deemed made.

Section 7. Costs and Expenses.  The Borrower shall pay not later than ten (10) Business Days after invoiced all reasonable out-of-pocket costs and expenses of the Administrative Agent (including the reasonable fees, charges and disbursements of counsel to the Administrative Agent) incurred in connection with the preparation, negotiation, execution and delivery of this Amendment, in each case, in accordance with Section 10.04 of the Credit Agreement.

Section 8. Governing Law.  THIS AMENDMENT AND ANY CLAIMS, CONTROVERSY, DISPUTE OR CAUSE OF ACTION (WHETHER IN CONTRACT OR TORT OR OTHERWISE) BASED UPON, ARISING OUT OF OR RELATING TO THIS AMENDMENT AND THE TRANSACTIONS CONTEMPLATED HEREBY SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK.

Section 9. Execution.  This Amendment may be executed in any number of counterparts and by different parties hereto in separate counterparts, each of which when so executed shall be deemed to be an original and all of which taken together shall constitute one and the same agreement.  Delivery of an executed counterpart of a signature page to this Amendment by telecopier (or electronic mail (including in PDF format)) shall be effective as delivery of a manually executed counterpart of this Amendment.

Section 10. Limited Effect.  This Amendment relates only to the specific matters expressly covered herein, shall not be considered to be an amendment or waiver of any rights or remedies that the Administrative Agent or any Lender may have under the Credit Agreement or under any other Loan Document (in each case, except as expressly set forth herein) or under Law, and shall not be considered to create a course of dealing or to otherwise obligate in any respect the Administrative Agent or any Lender to execute similar or other amendments, consents, or waivers or grant any amendments, consents or waivers under the same or similar or other circumstances in the future.

Section 11. Ratification by Guarantors.  Each of the Guarantors acknowledges that its consent to this Amendment is not required, but each of the undersigned nevertheless does hereby agree and consent to this Amendment and to the documents and agreements referred to herein.  Each of the Guarantors agrees and acknowledges that (i) notwithstanding the effectiveness of this Amendment, such Guarantor's Guaranty shall remain in full force and effect without modification thereto and (ii) nothing herein shall in any way limit any of the terms or provisions of such Guarantor's Guaranty or any other Loan Document executed by such Guarantor (as the same may be amended from time to time), all of which are hereby ratified, confirmed and affirmed in all respects.  Each of the Guarantors hereby agrees and acknowledges that no other agreement, instrument, consent or document shall be required to give effect to this Section 11.

[Signature Pages Follow]

IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed and delivered as of the date first above written.

BORROWER:

EMERGENT BIOSOLUTIONS INC.

 

By: /s/ROBERT G. KRAMER

Name: Robert G. Kramer

Title: Chief Financial Officer and Treasurer

GUARANTORS:

EMERGENT BIODEFENSE OPERATIONS LANSING LLC

EMERGENT COMMERCIAL OPERATIONS FREDERICK INC.

EMERGENT INTERNATIONAL INC.

EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.

EMERGENT EUROPE INC.

EMERGENT PROTECTIVE PRODUCTS USA INC.

EMERGENT VIROLOGY LLC

By: /s/ROBERT G. KRAMER

Name: Robert G. Kramer

Title: Treasurer

 

GUARANTORS (cont'd):

400 PROFESSIONAL LLC

 

By: /s/ROBERT G. KRAMER

Name: Robert G. Kramer

Title: Vice President

CANGENE BIOPHARMA LLC

 

By: /s/MICHAEL R. DARLING

Name: Michael R. Darling

Title: Treasurer

EMERGENT MANUFACTURING OPERATIONS BALTIMORE LLC

 

By: /s/ROBERT G. KRAMER

Name: Robert G. Kramer

Title: Executive Manager

ADMINISTRATIVE AGENT:

BANK OF AMERICA, N.A.

 

By: /s/ERIK M. TRUETTE

Name: Erik M. Truette

Title: Vice President

LENDERS:

BANK OF AMERICA, N.A., as a Lender, a L/C Issuer and Swing Line Lender

 

By: /s/LORI JOU EGAN

Name: Lori Jou Egan

Title: Senior Vice President

LENDERS (cont'd):

JPMORGAN CHASE BANK, N.A. as a Lender and a L/C Issuer

 

By: /s/ANTHONY GALEA

Name: Anthony Galea

Title: Executive Director

LENDERS (cont'd):

PNC BANK, NATIONAL ASSOCIATION, as a Lender and L/C Issuer

 

By: /s/ERIC H. WILLIAMS

Name: Eric H. Williams

Title: Vice PresidentEXHIBIT 10.2

Confidential Materials omitted and filed separately with the

Securities and Exchange Commission. Double asterisks denote omissions.

	
AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT

	
1. CONTRACT ID CODE

	
PAGE OF PAGES

	
1

	
6

	
2. AMENDMENT/MODIFICATION NO.

0001

	
3. EFFECTIVE DATE

See Block 16C

 

	
4. REQUISITION/PURCHASE NO.

 

	
5. PROJECT NO. (If applicable)

 

	
6. ISSUED BY CODE

	
ASPR-BARDA

	
7. ADMINISTERED BY (If other than Item 6) CODE

	
ASPR-BARDA

	
ASPR-BARDA

200 Independence Ave., S.S.

Room 640-G

Washington, DC 20201

	
ASPR-BARDA

200 Independence Ave., S.S.

Room 638-G

Washington, DC 20201

	
8. NAME AND ADDRESS OF CONTRACTOR (No., Street, county, State and ZIP Code)

 

	
(x)

	
9A. AMENDMENT OF SOLICITATION NO.

	
 

EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.

EMERGENT PRODUCT DEVELOPMENT GAITHE

300 PROFESSIONAL DR # 100

GAITHERSBURG MD 208793419

	 	 
	 	
9B. DATED (SEE ITEM 11)

	 	 
	
x

	
10A. MODIFICATION OF CONTRACT/ORDER NO.

	
HHSO100201600030C

	 	
10B. DATED (SEE ITEM 13)

	
CODE    1365869

	
FACILITY CODE

	 	
09/30/2016

	
11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS

	
□ The above numbered solicitation is amended as set forth in Item 14.  The hour and date specified for receipt of Offers                     □ is extended, □ is not extended.

Offers must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended, by one of the following methods:  (a) By completing Items 8 and 15, and returning ____ copies of the amendment; (b) By acknowledging receipt of this amendment on each copy of the offer submitted; or  (c) By separate letter or telegram which includes a reference to the solicitation and amendment numbers.  FAILURE OF YOUR ACKNOWLEDGMENT TO BE RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT IN REJECTION OF YOUR OFFER.  If by virtue of this amendment you desire to change an offer already submitted, such change may be made by telegram or letter, provided each telegram or letter makes reference to the solicitation and this amendment, and is received prior to the opening hour and date specified.

	
12. ACCOUNTING AND APPROPRIATION DATA (If required)

See Schedule

	
13. THIS ITEM APPLIES ONLY TO MODIFICATIONS OF CONTRACTS/ORDERS.  IT MODIFIES THE CONTRACT/ORDER NO. AS DESCRIBED IN ITEM 14.

	
CHECK ONE

	
A. THIS CHANGE ORDER IS ISSUED PURSUANT TO: (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT ORDER NO. IN ITEM 10A.

	 
	 	
B. THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES (such as changes in paying office, appropriation date, etc) SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(b).

	 	
C. THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF:

 

	

X

	
D. OTHER (Specify type of modification and authority)

FAR 52.243-2 Changes – Cost Reimbursement

	
E. IMPORTANT:  Contractor   □ is not, ⊠ is required to sign this document and return     2    copies to the issuing office.

	
14. DESCRIPTION OF AMENDMENT/MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.)

Tax ID Number: [**]

DUNS Number: [**]

The purpose of this modification is to modify ARTICLES B.2 BASE PERIOD, B.3. OPTION PRICES, B.5. ADVANCE UNDERSTANDINGS, and SECTION 1 - CONTRACT CLAUSES.

 

Funds Obligated Prior to this Modification: $198,705,042

Funds Obligated with Mod #1: $0

Total Funds Obligated to Date: $198,705,042

 

Expiration Date: September 29,2021

Period of Performance: 09/30/2016 to 09/29/2021

	
Except as provided herein, all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect.

	
15A. NAME AND TITLE OF SIGNER (Type or print)

 

	
16A. NAME OF CONTRACTING OFFICER

CHRISTOPHER SCOTT

	
15B. CONTRACTOR/OFFEROR

 

 

  

(Signature of person authorized to sign)

	
15C. DATE SIGNED

	
16B. UNITED STATES OF AMERICA

By

 

  

(Signature of Contracting Officer)

	
16C. DATE SIGNED

NSN 7540-01-152-8070 STANDARD FORM 30 (Rev. 10-83)

Previous edition unusable Prescribed by GSA

FAR (48 CFR) 53.243

ARTICLE B.2. BASE PERIOD is hereby modified as follows:

	
CLIN

	
Period of

Performance

	
Supplies/ Services

	 	
Total Est. Cost

	 	 	
Fixed Fee

(7%)

	 	 	
Total Cost Plus

Fixed Fee

	 
	
 

COST REIMBURSEMENT

	 	 	 	 	 	 	 	 	 
	
0001 (Base)

	
09/30/2016 –

09/29/2021

	
Licensure, approval, and clearance of product through the FDA

	 	 	
[

	
**]

	 	 	
[

	
**]

	 	 	
[

	
**]

	
 

FIRM FIXED PRICE

	 	 	 	 	 	 	 	 	 	 	 	 
	
CLIN

	
Period of

Performance

	
Supplies/ Services

	 	
Units (# of

Doses)

	 	 	
Unit Price ($)

	 	 	
Total ($)

	 
	
0002

(Base)

	
09/30/2016 –

09/29/2021

	
Initial Purchase, Storage, and

Delivery of Product

	 	 	
3,000,000

	 	 	 	
[

	
**]

	 	 	
[

	
**]

	
Total

CLINS

1&2

	
09/30/2016 –

09/29/2021

	
See Above Descriptions

	 	 	 	 	 	 	 	 	 	
$198,705,042

(Funded)

	 

[**]

ARTICLE B.3. OPTION PRICES is hereby modified as follows:

	
CLIN

	
Period of

Performance

	
Supplies/ Services

	
Total Est. Cost

	
Fixed Fee

	
Total Cost

Plus Fixed

Fee ($)

	 	 	
 

COST REIMBURSEMENT

	 	 	 
	
0001A

(Option

Quantity)

	
[**]

	
Phase II [**] Study or

studies required by the FDA [**]

	
[**]

	
[**]

	
[**]

	
CLIN

	
Period of

Performance

	
Supplies/ Services

	
Total Est. Cost

	
Fixed Fee

	
Total Cost

Plus Fixed

Fee ($)

	 	 	
 

FIXED PRICE

	 	 	 
	
0003

(Option

Quantity)

	
[**]

	
Phase IV post marketing

commitments /Requirements (This is an option that may or may not be exercised during the base period as determined by the need and as established by the FDA)

	
N/A

	
N/A

	
[**]

	 
	
CLIN

	
Period of

Performance

	
Supplies/ Services

	
Units (# of

Product)

	
FY 2018

Unit Price

($)

	
Total ($)

	
0004A

(Option

Quantity)

	
[**]

	
Additional Surge Capacity (EUA)

 

 

	
7,500,000 to

[**]

	
[**]

	
[**]

	
0004B

(Option

Quantity)

	
[**]

	
Additional Surge Capacity

(Licensure)

	
7,500,000 to

[**]

	
[**]

	
[**]

	
0004C

(Option

Quantity)

	
[**]

	
Additional Surge Capacity (EUA)

	
[**]

	
[**]

	
[**]

	
0004D

(Option

Quantity)

	
[**]

	
Additional Surge Capacity

(Licensure)

	
[**]

	
[**]

	
[**]

	
0004E

(Option

Quantity)

	
[**]

	
Additional Surge Capacity (EUA)

	
[**]

	
[**]

	
[**]

	
0004F

(Option

Quantity)

	
[**]

	
Additional Surge Capacity

(Licensure)

	
[**]

	
[**]

	
[**]

	
0004G

(Option

Quantity)

	
[**]

	
Additional Surge Capacity (EUA)

	
[**]

	
[**]

	
[**]

	
0004H

(Option

Quantity)

	
[**]

	
Additional Surge Capacity

(Licensure)

	
[**]

	
[**]

	
[**]

[**]

ARTICLE B.5. ADVANCE UNDERSTANDINGS is hereby modified as follows:

h. Option CLINS

If procurement for CLIN 4 occurs after FY 2018, the following chart illustrates the dose prices to be used:

	
Units (# of Doses)

	
FY 2019 Unit

Price ($)

	
FY 2020 Unit

Price ($)

	
FY 2021 Unit

Price ($)

	
7,500,000 to

[**]

	
[**]

	
[**]

	
[**]

	
[**]

	
[**]

	
[**]

	
[**]

	
[**]

	
[**]

	
[**]

	
[**]

	
[**]

	
[**]

	
[**]

	
[**]

	
[**]

	
[**]

	
[**]

	
[**]

	
[**]

	
[**]

	
[**]

	
[**]

	
[**]

	
[**]

	
[**]

	
[**]

	
[**]

	
[**]

	
[**]

	
[**]

[**]

The USG reserves the right to re-negotiate the option CLINS based on availability of funds and feedback received from the FDA.

SECTION I - CONTRACT CLAUSES

ARTICLE I.1. FAR 52.252-2, CLAUSES INCORPORATED BY REFERENCE (FEBRUARY

	
1998)

	
is hereby modified to add FAR 52.219-9 as follows:

This contract incorporates the following clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at these addresses: https://www.acquisition.gov/FAR/ . HHSAR Clauses at: http://www.hhs.gov/policies/hhsar/subpart352.html .

General Clauses for Cost-Reimbursement/Fixed Price Research and Development Contract

(1) FEDERAL ACQUISITION REGULATION (FAR) (48 CFR CHAPTER 1) CLAUSES:

	
Reg

	
Clause

	
Date

	
Clause Title

	
FAR

	
52.202-1

	
Nov 2013

	
Definitions

	
FAR

	
52.203-3

	
Apr 1984

	
Gratuities

	
FAR

	
52.203-5

	
May 2014

	
Covenant Against Contingent Fees

	
FAR

	
52.203-6

	
Sep 2006

	
Restrictions on Subcontractor Sales to the Government

	
FAR

	
52.203-7

	
May 2014

	
Anti-Kickback Procedures

	
FAR

	
52.203-8

	
May 2014

	
Cancellation, Rescission, and Recovery of Funds for Illegal or Improper Activity

	
FAR

	
52.203-10

	
May 2014

	
Price or Fee Adjustment for Illegal or Improper Activity

	
FAR

	
52.203-12

	
Oct 2010

	
Limitation on Payments to Influence Certain Federal Transactions

	
FAR

	
52.203-13

	
Oct 2015

	
Contractor Code of Business Ethics and Conduct

	
FAR

	
52.203-14

	
Oct 2015

	
Display of Hotline Poster(s)

	
 

FAR

	
 

52.203-17

	
 

Apr 2014

	
Contractor Employee Whistleblower Rights and Requirement To Inform

Employees of Whistleblower Rights

	
FAR

	
52.204-4

	
May 2011

	
Printed or Copied Double-Sided on Postconsumer Fiber Content Paper

	
FAR

	
52.204-7

	
Jul 2013

	
System for Award Management

	
FAR

	
52.204-10

	
Oct 2015

	
Reporting Executive Compensation and First-Tier Subcontract Awards

	
FAR

	
52.204-13

	
Jul 2013

	
System for Award Management Maintenance

	
 

FAR

	
 

52.209-6

	
 

Oct 2015

	
Protecting the Government's Interests When Subcontracting With Contractors

Debarred, Suspended, or Proposed for Debarment

	
FAR

	
52.209-10

	
Nov 2015

	
Prohibition on Contracting with Inverted Domestic Corporations

	
FAR

	
52.210-1

	
Apr 2011

	
Market Research

	
FAR

	
52.215-2

	
Oct 2010

	
Audit and Records – Negotiation

	
FAR

	
52.215-8

	
Oct 1997

	
Order of Precedence - Uniform Contract Format

	
FAR

	
52.215-10

	
Aug 2011

	
Price Reduction for Defective Cost or Pricing Data

	
FAR

	
52.215-11

	
Aug 2011

	
Price Reduction for Defective Certified Cost or Pricing Data—Modifications.

	
FAR

	
52.215-12

	
Oct 2010

	
Subcontractor Certified Cost or Pricing Data

	
FAR

	
52.215-13

	
Oct 2010

	
Subcontractor Certified Cost or Pricing Data—Modifications

	
FAR

	
52.215-15

	
Oct 2010

	
Pension Adjustments and Asset Reversions

	
FAR

	
52.215-17

	
Oct 1997

	
Waiver of Facilities Capital Cost of Money

	
 

FAR

	
 

52.215-18

	
 

Jul 2005

	
Reversion or Adjustment of Plans for Postretirement Benefits (PRB) other than

Pensions

	
FAR

	
52.215-19

	
Oct 1997

	
Notification of Ownership Changes

	
 

FAR

	
 

52.215-21

	
 

Oct 2010

	
Requirements for Certified Cost or Pricing Data and Data Other Than Certified

Cost or Pricing Data -Modifications

	
FAR

	
52.215-23

	
Oct 2009

	
Limitations on Pass-Through Charges

	
FAR

	
52.216-7

	
Jun 2013

	
Allowable Cost and Payment

	
FAR

	
52.216-8

	
Jun 2011

	
Fixed Fee

	
FAR

	
52.219-8

	
Oct 2014

	
Utilization of Small Business Concerns

	
FAR

	
52.219-9

	
Nov 2016

	
Small Business Subcontracting Plan

	
FAR

	
52.219-28

	
July 2013

	
Post-Award Small Business Program Representation

	
FAR

	
52.222-1

	
Feb 1997

	
Notice to the Government of Labor Disputes

	
FAR

	
52.222-2

	
Jul 1990

	
Payment for Overtime Premiums

	
FAR

	
52.222-3

	
Jun2003

	
Convict Labor

	
FAR

	
52.222-21

	
Apr 2015

	
Prohibition of Segregated Facilities

	
FAR

	
52.222-26

	
Apr 2015

	
Equal Opportunity

	
FAR

	
52.222-35

	
Oct 2015

	
Equal Opportunity for Veterans

	
FAR

	
52.222-36

	
Jul 2014

	
Equal Opportunity for Workers with Disabilities

	
FAR

	
52.222-37

	
Feb 2016

	
Employment Reports on Veterans

	
FAR

	
52.222-40

	
Dec 2010

	
Notification of Employee Rights Under the National Labor Relations Act

	
 

FAR

	
 

52.222-43

	
 

May 2014

	
Fair Labor Standards Act and Service Contract Labor Standards—Price

Adjustment (Multiple Year and Option Contracts)

	
FAR

	
52.222-50

	
Mar 2015

	
Combating Trafficking in Persons

	
FAR

	
52.222-54

	
Oct 2015

	
Employment Eligibility Verification

	
FAR

	
52.223-6

	
May 2001

	
Drug-Free Workplace

	
FAR

	
52.223-18

	
Aug 2011

	
Encouraging Contractor Policy to Ban Text Messaging While Driving

	
FAR

	
52.224-1

	
April 1984

	
Privacy Act Notification

	
FAR

	
52.224-2

	
April 1984

	
Privacy Act

	
FAR

	
52.225-13

	
Jun 2008

	
Restrictions on Certain Foreign Purchases

	
FAR

	
52.227-1

	
Dec 2007

	
Authorization and Consent, Alternate 1 (APR 1984)

	
FAR

	
52.227-2

	
Dec 2007

	
Notice and Assistance Regarding Patent and Copyright Infringement

	
FAR

	
52.227-3

	
Apr 1984

	
Patent Indemnity

	
FAR

	
52.227-11

	
May 2014

	
Patent Rights – Ownership by the Contractor

	
FAR

	
52.227-14

	
May 2014

	
Rights in Data - General

	
FAR

	
52.227-16

	
Jun 1987

	
Additional Data Requirements

	
FAR

	
52.228-7

	
Mar 1996

	
Insurance – Liability to Third Persons

	
FAR

	
52.229-3

	
Feb 2013

	
Federal, State and Local Taxes

	
FAR

	
52.230-2

	
Oct 2015

	
Cost Accounting Standards

	
FAR

	
52.230-6

	
June 2010

	
Administration of Cost Accounting Standards

	
FAR

	
52.232-1

	
Apr 1984

	
Payments

	
FAR

	
52.232-2

	
Apr 1984

	
Payments under Fixed-Price Research and Development Contracts

	
FAR

	
52.232-8

	
Feb 2002

	
Discounts for Prompt Payment

	
FAR

	
52.232-9

	
Apr 1984

	
Limitation on Withholding of Payments

	
FAR

	
52.232-11

	
Apr 1984

	
Extras

	
FAR

	
52.232-17

	
May 2014

	
Interest

	
FAR

	
52.232-20

	
Apr 1984

	
Limitation of Cost

	
FAR

	
52.232-23

	
May 2014

	
Assignment of Claims

	
FAR

	
52.232-25

	
Jul 2013

	
Prompt Payment

	
FAR

	
52.232-33

	
Jul 2013

	
Payment by Electronic Funds Transfer--System for Award Management

	
FAR

	
52.233-1

	
May 2014

	
Disputes

	
FAR

	
52.233-3

	
Aug 1996

	
Protest After Award, Alternate I

	
FAR

	
52.233-4

	
Oct 2004

	
Applicable Law for Breach of Contract Claim

	
FAR

	
52.242-1

	
Apr 1984

	
Notice of Intent to Disallow Costs

	
FAR

	
52.242-3

	
May 2014

	
Penalties for Unallowable Costs

	
FAR

	
52.242-4

	
Jan 1997

	
Certification of Final Indirect Costs

	
FAR

	
52.242-13

	
Jul 1995

	
Bankruptcy

	
FAR

	
52.243-1

	
Aug 1987

	
Changes - Fixed-Price Alternate V (Apr 1984).

	
FAR

	
52.243-2

	
Aug 1987

	
Changes—Cost-Reimbursement Alternate V (Apr 1984).

	
FAR

	
52.243.6

	
Apr 1984

	
Change Order Accounting

	
FAR

	
52.243-7

	
Apr 1984

	
Notification of Changes

	
FAR

	
52.244-2

	
Oct 2010

	
Subcontracts, Alternate 1 (Jun 2007)

	
FAR

	
52.244-5

	
Dec 1996

	
Competition in Subcontracting

	
FAR

	
52.244-6

	
Apr 2015

	
Subcontracts for Commercial Items

	
FAR

	
52.245-1

	
Apr 2012

	
Government Property

	
FAR

	
52.245-9

	
Apr 2012

	
Use and Charges

	
FAR

	
52.246-7

	
Apr 1996

	
Inspection of Research and Development – Fixed-Price

	
FAR

	
52.246-8

	
May 2001

	
Inspection of Research and Development – Cost-Reimbursement

	
FAR

	
52.246-23

	
Feb 1997

	
Limitation of Liability.

	
FAR

	
52.246-25

	
Feb 1997

	
Limitation of Liability—Services

	
FAR

	
52.248-1

	
Oct 2010

	
Value Engineering

	
FAR

	
52.249-2

	
Apr 2012

	
Termination for the Convenience of the Government (Fixed-Price)

	
FAR

	
52.249-6

	
May 2004

	
Termination (Cost-Reimbursement)

	
FAR

	
52.249-8

	
Apr 1984

	
Default (Fixed-Price Supply and Service)

	
FAR

	
52.249-9

	
Apr 1984

	
Default (Fixed-Price Research and Development)

	
FAR

	
52.249-14

	
Apr 1984

	
Excusable Delays

	
FAR

	
52.253-1

	
Jan 1991

	
Computer Generated Forms

All other terms and conditions of this contract remain unchanged.

End of Modification #1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00270-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00270-of-00352.parquet"}]]